CHRB Faces Another Delay In Third-Party Furosemide Administration: Paulick Report 2/7/17

By: Ray Paulick Efforts by the California Horse Racing Board to begin third-party administration of the anti-bleeder medication furosemide (Salix, formerly Lasix) – initiated in 2012 – suffered another setback last week when the state of California's Office of Administrative Law disapproved an amendment to sections 1433 and 1845 of Title 4 the California Code

CHRB Member Calls for Trainer ‘Profiling’:Blood-Horse 8/24/16

By: Jeremy Balan California Horse Racing Board member Madeline Auerbach, at an Aug. 24 meeting of the agency's Medication and Track Safety Committee, called for increased scrutiny on certain trainers through "profiling." The Wednesday meeting at Del Mar touched on several topics, from cell phone use by exercise riders to drug policies employed in New